title: Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats.
abstract: Pulmonary arterial hypertension (PAH) is a progressive disease associated with increased constriction and remodeling of the pulmonary vasculature. Quercetin is a natural flavonoid and has a variety of pharmacological effects including improvement of endothelial cell function. However, its pharmacological effects on pulmonary hypertension have been rarely reported. We sought to observe the protective effect of quercetin in rats with monocrotaline induced PAH. We divided 30 male Sprague-Dawley rats randomly into three groups with ten rats in each group: the monocrotaline group, the quercetin group and the control group. We found that, compared with the controls, the mean pulmonary artery pressure (mPAP) and the right ventricular hypertrophy index in the monocrotaline group were significantly higher (P < 0.01). Quercetin caused a significant reduction both in the mPAP and right ventricular hypertrophy index compared with the monocrotaline group (P < 0.01) while no difference was found between the quercetin group and the control group (P > 0.05). Monocrotaline induced a marked increase in the wall thickness (WT) in small and mid-sized pulmonary arteries compared with the controls (P < 0.01). Monocrotaline also induced a marked increase in the wall area (WA) in small [(56.38±6.65)% in monocrotaline vs. (19.80±4.63)% in control] and mid-sized [(43.71±5.38)% in monocrotaline vs. (14.24±3.66)% in control] pulmonary arteries (P < 0.01). Quercetin treatment markedly reduced monocrotaline induced increase in both WT and WA (P < 0.01), which, however, still remained significantly elevated compared with those of the controls (P < 0.01). Furthermore, compared with controls, proliferating cell nuclear antigen (PCNA) expression in the pulmonary artery tissues was markedly increased by monocrotaline [(45.59±1.27) in monocrotaline vs. (9.64±0.69) in controls], which was significantly attenuated by quercetin. Our animal experiment indicated that quercetin could have protective effects on monocrotaline-induced PAH.
authors.affiliation: Department of Cardiology, the Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China.
authors.forename: Hanhua
authors.initials: H
authors.lastname: Gao
authors.forename: Can
authors.initials: C
authors.lastname: Chen
authors.forename: Shi'an
authors.initials: S
authors.lastname: Huang
authors.forename: Bo
authors.initials: B
authors.lastname: Li
keywords: PCNA; monocrotaline; pulmonary arterial hypertension; quercetin
references.citation: Circulation. 1992 Aug;86(2):538-47
references.pmid: 1353419
references.citation: Can J Vet Res. 1992 Jul;56(3):214-9
references.pmid: 1423057
references.citation: J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):25S-32S
references.pmid: 15194175
references.citation: Folia Morphol (Warsz). 2004 Feb;63(1):103-5
references.pmid: 15039912
references.citation: J Surg Res. 2005 May 1;125(1):49-55
references.pmid: 15836850
references.citation: Zhonghua Nei Ke Za Zhi. 2006 Jun;45(6):467-71
references.pmid: 16831323
references.citation: Eur Respir J. 2005 Dec;26(6):1110-8
references.pmid: 16319344
references.citation: Am J Pathol. 1999 Aug;155(2):411-9
references.pmid: 10433934
references.citation: J Clin Invest. 2005 Oct;115(10):2811-21
references.pmid: 16200212
references.citation: Pathol Res Pract. 1993 Jun;189(5):567-76
references.pmid: 8378180
references.citation: Circ Res. 1995 Feb;76(2):168-75
references.pmid: 7834826
references.citation: Am J Physiol. 1991 Feb;260(2 Pt 2):H642-6
references.pmid: 1996708
references.citation: Nat Med. 2000 Jun;6(6):698-702
references.pmid: 10835689
references.citation: Zhong Yao Cai. 2002 Apr;25(4):268-70
references.pmid: 12583178
references.citation: Am J Pathol. 1994 Feb;144(2):275-85
references.pmid: 7508683
references.citation: Toxicol Appl Pharmacol. 1998 Aug;151(2):236-44
references.pmid: 9707500